Questions? Chat with the founder on WhatsApp

Chat with the founder on WhatsApp
Arthneeti
HomeRankingsIPOScreenerInstitutions
HomeRankingsIPOScreenerInstitutions
Vasa Denticity LtdQ1 FY27Healthcare Equipment & Supplies
Home/Stocks/Vasa Denticity Ltd/Q1 FY27

Vasa Denticity Ltd Q1 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹423P/E: 62.4Market Cap: ₹673 CrSector: Healthcare Equipment & Supplies

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

No

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • →The company aims to achieve revenue between ₹800 to ₹1200 crores over the next 5 years, indicating strong growth aspirations.
  • →Revenue growth targets for FY27 are around ₹500-600 crores and ₹800-1200 crores for FY28, reflecting ambitious scaling plans.
  • →Growth is expected to be driven primarily by increasing average order value and repeat purchases rather than acquiring new customers.
  • →There is a focus on increasing order frequency and customer wallet share through strategies like discounts on multiple items and tech solutions offering incentives.
  • →New business lines like digital dentistry equipment (intraoral scanners, 3D printers) are becoming significant growth drivers.
  • →Organic growth is prioritized over acquisitions currently, with inorganic opportunities considered only if organic growth plateaus.
  • →Expansion plans include extending same-day or next-day delivery beyond tier-1 cities to tier 2 and 3 cities to drive volumes.
  • →The company anticipates sustained or improved gross margins around 27-33%, balancing growth with fair pricing.

Margin guidance

Category 2
  • →The company targets a gross margin range of 27-30% medium-term, with a cautious approach not to exceed 33% to pass benefits to customers.
  • →Revenue growth is expected to continue at a rate similar to the first quarter's year-on-year growth, led by increasing order frequency and average order value.
  • →Focus on operational efficiencies (e.g., automation, optimized warehousing) aims to reduce cost-to-serve per order, improving operating margins.
  • →New business lines like digital dentistry equipment are gaining traction, offering deeper client relationships and additional revenue streams.
  • →Non-product revenue streams (e.g., education webinars, demos) are expected to contribute to margin expansion beyond 33%.
  • →Hiring senior leadership and strengthening teams to improve execution and scaling.
  • →No explicit formal guidance for FY27/28 revenues but long-term targets range from ₹800–1200 crores in five years.
  • →Overall, disciplined execution with emphasis on sustainable, profitable growth and improved operational control.

3 more insights locked — sign up free to unlock

Fundraise plans

No
  • →There is no mention of any current or immediate plans for new fundraising through debt or equity.
  • →The company is focusing on organic growth and improving its core business rather than acquisitions or external funding.
  • →They have consciously chosen not to pursue acquisitions this year and are instead concentrating on strategy and strengthening their team.
  • →The management indicated that if organic growth in a particular category becomes difficult in the future, they might consider inorganic opportunities like buyouts, but currently, there is no such plan.
  • →Cash on hand will be used as working capital for the company, not for external fundraising (Page 21).

Order book

The transcript in the provided pages does not explicitly mention current or expected orderbook or pending orders figures. However, some related insights include: - The focus is on increasing orders per customer and number of customers, with strategies planned though no definitive guidance on growth percentages yet (Page 21). - Order volumes showed growth: quarter volumes moved from 1.58 lakh & 1.82 lakh (previous year) to 1.75 lakh & 2.04 lakh recently after correction of internal errors (Page 9). - Average order value increased by about 27% largely due to higher ticket-size products; order volume growth was around 8% (Page 6). - Efforts are on increasing order frequency, average revenue per user (RPU), and leveraging membership growth to boost orders (Page 21). - Supply chain improvements and inventory buffer are being implemented to support growing order volumes and reduce stockouts (Page 10). No explicit numeric orderbook or pending orders data was disclosed.

Capex plans

Yes
  • →The company is focusing on building control through in-house brands to ensure quality, pricing, and product availability, which involves capital and attention investment in these portfolios.
  • →Expansion into digital dentistry division (intraoral scanners, milling machines, 3D printers, imaging products) is underway and is no longer an experiment, indicating ongoing strategic investment in this segment.
  • →Inventory management and supply chain improvements are being made, including forward deployment and demand forecasting to reduce stockouts and improve delivery times, implying operational capital investment.
  • →The company is optimizing warehousing and logistics, with initiatives like Insta Dent for same-day/next-day delivery, requiring investment in regional warehouses.
  • →Hiring senior leadership and building the right management team, including VP marketing and supply chain, are part of their strategic focus on people and operational capability.
  • →No current plans for acquisitions, focusing on organic growth and internal capacity-building first.

How does Vasa Denticity Ltd rank vs peers in Healthcare Equipment & Supplies?

Pro feature
1Vasa Denticity Ltd
Rev 3Mar 2
2Healthcare Equipment & Supplies Company A
Rev 1Mar 2
3Healthcare Equipment & Supplies Company B
Rev 2Mar 1
4Healthcare Equipment & Supplies Company C
Rev 2Mar 3

See full Healthcare Equipment & Supplies sector rankings

How does Vasa Denticity Ltd rank in Healthcare Equipment & Supplies?

Compare Vasa Denticity Ltd against every Healthcare Equipment & Supplies company (Q1 FY27) on revenue, margins and earnings-call signals.

View Healthcare Equipment & Supplies leaderboard →

Related research

Read the full Q1 FY27 earnings insight — Vasa Denticity Ltd

Other quarters — Vasa Denticity Ltd

Q4 FY26Q2 FY26Q4 FY25Q2 FY25Q4 FY24Q2 FY24

Healthcare Equipment & Supplies peers

Fischer Medical · Q2 FY26Poly Medicure · Q1 FY27Prevest Denpro Ltd · Q1 FY27Tarsons Products · Q1 FY27Vaidya Sane · Q2 FY26
Vasa Denticity Ltd full stock analysisHealthcare Equipment & Supplies sectorEarnings call directoryRankings dashboard

Questions about this analysis? Chat directly with the founder — real answers about the research, not a support bot.

WhatsApp the founder

Research team or advisory firm? Get earnings-call intelligence and ranking history as research inputs for your firm.

For Institutions

Arthneeti AI

AI-powered stock analysis from earnings call transcripts. Helping Indian investors make smarter decisions with data-driven insights.

Analysis

  • Stock Rankings
  • Sectors
  • Compare Stocks
  • IPO Dashboard
  • Stock Screener
  • Earnings Call Analysis
  • Stocks Under ₹500
  • Multibaggers

Tools

  • MF Overlap Checker
  • SIP Calculator
  • CAGR Calculator
  • FD vs Equity
  • All Calculators

Resources

  • Blog
  • Weekly Digest
  • Portfolio Analysis
  • Build Portfolio
  • Earnings Calendar
  • Q1 FY27 Earnings Hub

Company

  • Pricing
  • How Our Analysis Works
  • For Institutions
  • Terms of Service
  • Privacy Policy

Compare

  • vs Screener.in
  • vs Trendlyne
  • vs Tickertape
  • vs Moneycontrol Pro
+91 90841 32575 support@arthneeti.com Bengaluru, India

© 2026 Arthneeti AI. All rights reserved.

AI-analyzed data from 1,500+ company earnings calls

Continue your research

What Vasa Denticity Ltd's management said in earlier quarters

  • Q1 FY27 earnings call analysis →
  • Q2 FY26 earnings call analysis →

Others in Healthcare Equipment & Supplies this season

  • Prevest Denpro Ltd (Q1 FY27)

    Digital dentistry revenue, especially 3D printing resins, grew 40% this year; 3D printer sales rose by 162%, indicating strong growth potential, with plans for…

  • Poly Medicure (Q1 FY27)

    Europe and Southeast Asia markets are key growth drivers currently, with Europe showing 17%+ growth in Q1. Key concall takeaways from Poly Medicure's Q1 FY27…

  • Tarsons Products (Q1 FY27)

    Cash profitability grew 18% YoY in Q1 FY’27, showing underlying strength; profits remain moderate in FY’27 due to higher depreciation and interest but will…

  • Poly Medicure (Q3 FY26)

    New acquisitions and subsidiaries, such as Plan1 Health (oncology business), are contributing significant growth (e.g., 30-35% year-on-year for Plan1 Health)…

Compare:vs Poly Medicurevs Fischer Medicalvs Tarsons Products